Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6744)
All Articles published online
|
Publishing Process of This Article
|
Aug 10, 2015 (publication date) through Jun 2, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Badiani B, Maratea D, Messori A. Second-line treatments for advanced gastric cancer: Interpreting outcomes by network meta-analysis. World J Clin Oncol 2015; 6(4): 73-79 [PMID: 26266104 DOI: 10.5306/wjco.v6.i4.73] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v6/i4/73.htm |
| Number | Citing Articles |
| 1 |
|
| 2 |
Ning-ning Bian, Yong-hong Wang, Guang-tao Min. S-1 combined with paclitaxel may benefit advanced gastric cancer: Evidence from a systematic review and meta-analysis. International Journal of Surgery 2019; 62: 34 doi: 10.1016/j.ijsu.2018.11.010
|
| 3 |
Rebecca C. Harvey. Second-line Treatments for Advanced Gastric Cancer: A Network Meta-Analysis of Overall Survival Using Parametric Modelling Methods. Oncology and Therapy 2017; 5(1): 53 doi: 10.1007/s40487-017-0048-0
|
| 4 |
Zheng Ren, Jinping Sun, Xinfang Sun, Hongtao Hou, Ke Li, Quanxing Ge. Efficacy and safety of different molecular targeted agents based on chemotherapy for gastric cancer patients treatment: a network meta-analysis. Oncotarget 2017; 8(29): 48253 doi: 10.18632/oncotarget.17192
|
| 5 |
Dong-Mei Wu, Shan Wang, Xin Wen, Xin-Rui Han, Yong-Jian Wang, Min Shen, Shao-Hua Fan, Zi-Feng Zhang, Juan Zhuang, Qun Shan, Meng-Qiu Li, Bin Hu, Chun-Hui Sun, Jun Lu, Yuan-Lin Zheng. Survival Benefit of Three Different Therapies in Postoperative Patients With Advanced Gastric Cancer: A Network Meta-Analysis. Frontiers in Pharmacology 2018; 9 doi: 10.3389/fphar.2018.00929
|
| 6 |
Yong Zhang, Bing Ma, Xiao-Tian Huang, Yan-Song Li, Yu Wang, Zhou-Lu Liu. Doublet Versus Single Agent as Second-Line Treatment for Advanced Gastric Cancer. Medicine 2016; 95(8): e2792 doi: 10.1097/MD.0000000000002792
|
| 7 |
Xiaolong Qi, Yanna Liu, Wei Wang, Danxian Cai, Wende Li, Jialiang Hui, Chuan Liu, Yanxia Zhao, Guoxin Li. Management of advanced gastric cancer: An overview of major findings from meta-analysis. Oncotarget 2016; 7(47): 78180 doi: 10.18632/oncotarget.12102
|
| 8 |
Ji Cheng, Ming Cai, Xiaoming Shuai, Jinbo Gao, Guobin Wang, Kaixiong Tao. Systemic therapy for previously treated advanced gastric cancer: A systematic review and network meta-analysis. Critical Reviews in Oncology/Hematology 2019; 143: 27 doi: 10.1016/j.critrevonc.2019.08.001
|
| 9 |
Sejung Park, Chung Mo Nam, Seul-Gi Kim, Ji Eun Mun, Sun Young Rha, Hyun Cheol Chung. Comparative efficacy and tolerability of third-line treatments for advanced gastric cancer: A systematic review with Bayesian network meta-analysis. European Journal of Cancer 2021; 144: 49 doi: 10.1016/j.ejca.2020.10.030
|
| 10 |
Wing-lok Chan, Ka-on Lam, Tsz-him So, Victor Ho-fun Lee, Lai-wan Dora Kwong. Third-line systemic treatment in advanced/metastatic gastric cancer: a comprehensive review. Therapeutic Advances in Medical Oncology 2019; 11: 175883591985999 doi: 10.1177/1758835919859990
|